Ivan Sini

Ivan Sini

Auto-generated profile, based on publicly available information

Ivan Sini

Morula IVF Jakarta Clinic, Jakarta, Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2021 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
CLClaudio Michael Louis
Claudio Michael Louis
AEAlva Erwin
Alva Erwin
NHNining Handayani
Nining Handayani
APArie A. Polim
Arie A. Polim
ABArief Boediono
Arief Boediono
ISIvan Sini
Ivan Sini

2 May 2023 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
NHNining Handayani
Nining Handayani
DADaniel Aubry
Daniel Aubry
ABArief Boediono
Arief Boediono
BWBudi Wiweko
Budi Wiweko
BSBatara Sirait
Batara Sirait
Anom BowolaksonoAnom Bowolaksono
Anom Bowolaksono

27 April 2023 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
CTChii-Ruey Tzeng
Chii-Ruey Tzeng
ZHZhongwei Huang
Zhongwei Huang
YAYoshimasa Asada
Yoshimasa Asada
CZCuilian Zhang
Cuilian Zhang
MHManh Tuong Ho
Manh Tuong Ho
THTuong Nguyen Ho
Tuong Nguyen Ho
How do age, ethnicity, and other characteristics affect serum anti-mullerian hormone (AMH) levels in Asian women undergoing fertility treatment? Age, ethnicity, obesity (BMI ≥ 30 kg/m2), and polycystic ovarian syndrome (PCOS) significantly impacted serum AMH levels, with the rate of decrease accelerating as age increased; a concentration of 4.0 ng/ml was the optimal cut-off for diagnosis of PCOS. There are significant differences in ovarian reserve among women from different races and ethnicities, and Asian women often have poorer reproductive outcomes during assisted reproductive treatment cycles. A population-based multi-nation, multi-centre, multi-ethnicity prospective cohort study of 4613 women was conducted from January 2020 to May 2021. Infertile women of 20–43 years of age were enrolled. The exclusion criteria included: age 43, non-Asian ethnicity, and missing critical data. Participants were Asian women of Chinese, Japanese, Korean, Thai, Vietnamese, Malay, Indian, and Indonesian ethnicities from 12 IVF centres across Asia. These women were all naïve to ovarian stimulation cycles and attended IVF centres for fertility assessment. The AMH measurement was performed using an AMH automated assay on a clinically validated platform. A total of 4556 infertile Asian women were included in the final analyses. The mean ± SD for serum AMH concentrations (ng/ml) across specific age groups were: overall, 3.44 ± 2.93; age <30, 4.58 ± 3.16; 30–31, 4.23 ± 3.23; 32–33, 3.90 ± 3.06; 34–35, 3.21 ± 2.65; 36–37, 2.74 ± 2.44; 38–39, 2.30 ± 1.91; 40 and above, 1.67 ± 2.00. The rate of AMH decrease was ∼0.13 ng/ml/year in patients aged 25–33 and 0.31 ng/ml/year in women aged 33–43. The highest rates of PCOS were found in Indians (18.6%), Malays (18.9%), and Vietnamese (17.7%). Age (P < 0.001), ethnicity (P < 0.001), obesity (P = 0.007), PCOS (P < 0.001), and a history of endometrioma cystectomy (P = 0.01) were significantly associated with serum AMH values. Smoking status, pretreatment with GnRH agonist (GnRHa) or the oral contraceptive pill (OCP), freezing-thawing of blood samples, and sampling on Day 2 to Day 5 of the menstrual cycle or randomly did not appear to affect serum AMH levels. An AMH concentration of 4.0 ng/ml was the optimal cut-off for PCOS diagnosis with a sensitivity of 71.7% and specificity of 75.8% (AUC = 0.81, CI 95%: 0.79–0.83; P < 0.001). The incidence of PCOS was supposedly high in this cohort as some IVF clinics were tertiary referral centres for managing specific fertility issues encountered by women with PCOS. Treatment with GnRHa or OCP before AMH testing was regionally and ethnically confined, mostly in Hong Kong SAR and Japan. Moreover, this reference for serum AMH value is limited to Asian women of the ethnicities examined and may not apply to other ethnicities not included in the study. This is the first study to collate and construct age-specific reference ranges for serum AMH levels using the same bioassay on Asian women of different ethnicities. The findings of this investigation can assist clinicians to counsel and prognosticate about Asian women’s ovarian reserve and reproductive potential, thus providing better strategies for personalized fertility interventions. This study was technically supported by Ferring Pharmaceuticals and received no specific grant from any funding agency. All authors have no competing interests to disclose. NCT04203355.

2 August 2022 in Journal of Ultrasound
Verified
Journal Article
Closed access
PDF file
RKRaden Aditya Kusuma
Raden Aditya Kusuma
DNDetty Siti Nurdiati
Detty Siti Nurdiati
AFAdly Nanda Al Fattah
Adly Nanda Al Fattah
DDDidi Danukusumo
Didi Danukusumo
SASarini Abdullah
Sarini Abdullah
ISIvan Sini
Ivan Sini

28 February 2022 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
PDF file
ISIvan Sini
Ivan Sini
NHNining Handayani
Nining Handayani
AHAlida Harahap
Alida Harahap
ABArief Boediono
Arief Boediono
BWBudi Wiweko
Budi Wiweko
APAryando Pradana
Aryando Pradana
Purpose: This pilot study aimed to evaluate the potential synergistic role of three-dimensional power Doppler angiography ultrasound and the expression of Leukemia Inhibitory Factor (LIF) protein in predicting the endometrial receptivity of fresh In-Vitro Fertilization (IVF) cycles. Materials and methods: This prognostic cohort study involved 29 good prognosis women who underwent fresh IVF cycles with fresh blastocysts transfer. Serial measurements of sub-endometrial parameters including vascularity index (VI), flow index (FI), and vascularization flow index (VFI) were conducted consecutively via power Doppler angiography on the day of oocyte maturation trigger, oocyte retrieval, and blastocyst transfer. Aspiration of endometrial secretion was performed on the day of embryo transfer. Results: The mean index of VI and VFI on the trigger and oocyte retrieval day and also LIF protein concentration at the window of implantation were significantly higher in clinically pregnant women than that of the non-pregnant women (p < 0.05). The area under the curve (AUC) of VI and VFI was shown to have a powerful predictive value to forecast receptive endometrium on either trigger day (0.788 and 0.813, respectively) or oocyte retrieval day (0.813 and 0.818). Likewise, LIF concentration on the day of embryo transfer was adequate to become a predictor for endometrial receptivity (AUC 0.874). A combination of the VI and VFI on the trigger day and LIF concentration at specific cut-off values (VI > 5.381, VFI > 1.483, LIF 703.5 pg/mL) produced an algorithm with high AUC (0.881) and high specificity (94.4%) for an adequate prediction of non-receptive endometrium. Conclusion: VI and VFI index assessed on maturation trigger day and the expression of LIF protein concentration at the window of implantation provided sufficient information to predict endometrial receptivity. A large randomized control trial is needed to validate these findings.

31 May 2024 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
NHNining Handayani
Nining Handayani
DADaniel Aubry
Daniel Aubry
ABArief Boediono
Arief Boediono
Anom BowolaksonoAnom Bowolaksono
Anom Bowolaksono
ISIvan Sini
Ivan Sini
BWBudi Wiweko
Budi Wiweko